Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Top 20 Shareholders 14 December 2018

Top_Holders_Report (14)Download

Category: News & Announcements 2018By Richard Mollard December 17, 2018

Related posts

Top 20 Shareholders 30th December 2018
January 7, 2019

PharmAust Manufacturing Method Maintains Drug Potency
December 2, 2018

GMP Tablet Production for Clinical Trials Commences
November 13, 2018

2018 AGM Results
November 9, 2018

2018 AGM Presentation
November 9, 2018

Top 20 Shareholders 31st October 2018
November 6, 2018

Recent Articles

February 15, Canine Monepantel Phase IIb Lymphoma Trial Update
February 14, 2021
February 10, LUMC Covid-19 Research Update
February 10, 2021
January 31, Top 20 Shareholders
February 1, 2021
January 27, Appendix 4C and Quarterly Update
January 27, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

“We think products such as MPL will happily co-exist with vaccines,” $PAA Executive Chairman, Dr Roger Aston told @StockheadAU yesterday.

https://stockhead.com.au/health/so-covid-vaccines-are-here-what-now-for-all-those-biotechs-working-on-covid-19-drugs-or-tests/

Reply on Twitter 1364338373138161666 Retweet on Twitter 13643383731381616664 Like on Twitter 13643383731381616666 Twitter 1364338373138161666

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions